NCT05679453View on ClinicalTrials.gov

Lornoxicam Versus Etodolac After Third Molar Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

September 25, 2022

Study Completion Date

September 29, 2022

Conditions
Pain, AcuteEdemaTrismus
Interventions
DRUG

Lornoxicam 8 Mg Oral Tablet

Lornoxicam is a oxicam grup non-steroid antiinflamatuar drug

Trial Locations (1)

43000

Zülfikar Karabıyık, Kütahya

All Listed Sponsors
lead

Kutahya Health Sciences University

OTHER